SMART-PD: Evaluating the Impact of Smartphone-Based Wearable Technology on Motor Symptoms and Quality of Life in People With Parkinson's Disease

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorWestern University

About this trial

This study aims to evaluate whether wearable technology can improve the management of motor symptoms in people with Parkinson's disease (PD) who experience motor fluctuations throughout the day. The project will use a smartwatch and mobile app (KinesiaU) to continuously track movement, allowing for more responsive and personalized treatment compared to traditional monitoring methods.

In this pilot randomized controlled trial, 32 participants will be assigned to either:

A control group receiving standard care, or

A wearable device group receiving standard care plus using the smartwatch.

Outcomes will be assessed over a 4-week period, focusing on changes in motor function, quality of life, and self-management. The study will also examine feasibility, adherence, and data quality.

If successful, this trial will provide critical evidence for integrating wearable devices into routine clinical care for PD, paving the way for larger efficacy trials and more patient-centered care strategies.

Eligibility criteria

Qualifiers

Meet criteria for Parkinson's disease using MDS Clinical Diagnostic Criteria for Parkinson's Disease

Presence of Motor fluctuations based on movement disorder neurologist assessment.

Motor ability to use the wearable device and access the wearable device application.

Cognitively ability to do ADL's and use the wearable device and access the wearable device application based on clinician's judgment.

Disqualifiers

Physical barriers in using the wearable device.

Atypical Parkinsonian disorder or other causes of Parkinsonism

Inability to read or write English.

Trial design

Treatments tested in this trial

  • Kinesia U
  • Standard of care treatment

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Western University

Lead sponsor

Academic Medical Organization of Southwestern Ontario

Collaborator